Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial Resistance

被引:12
|
作者
Balas, Reka Borka [1 ]
Melit, Lorena Elena [1 ]
Marginean, Cristina Oana [1 ]
机构
[1] George Emil Palade Univ Med Pharm Sci & Technol, Dept Pediat 1, Gheorghe Marinescu St 38, Targu Mures 540136, Romania
来源
CHILDREN-BASEL | 2023年 / 10卷 / 02期
关键词
Helicobacter pylori; antimicrobial resistance; children; STANDARD TRIPLE THERAPY; SECONDARY ANTIBIOTIC-RESISTANCE; CLARITHROMYCIN RESISTANCE; HIGH PREVALENCE; LEVOFLOXACIN RESISTANCE; ISRAELI CHILDREN; BABA2; GENOTYPES; INFECTION; ADOLESCENTS; ERADICATION;
D O I
10.3390/children10020403
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Helicobacter pylori (H. pylori) has acquired several resistance mechanisms in order to escape the currently used eradication regimens such as mutations that impair the replication, recombination, and transcription of DNA; the antibiotics capability to interact with protein synthesis and ribosomal activity; the adequate redox state of bacterial cells; or the penicillin-binding proteins. The aim of this review was to identify the differences in pediatric H. pylori antimicrobial-resistance trends between continents and countries of the same continent. In Asian pediatric patients, the greatest antimicrobial resistance was found to metronidazole (>50%), probably due to its wide use for parasitic infections. Aside from the increased resistance to metronidazole, the reports from different Asian countries indicated also high resistance rates to clarithromycin, suggesting that ciprofloxacin-based eradication therapy and bismuth-based quadruple therapy might be optimal choices for the eradication of H. pylori in Asian pediatric population. The scarce evidence for America revealed that H. pylori strains display an increased resistance to clarithromycin (up to 79.6%), but not all studies agreed on this statement. Pediatric patients from Africa also presented the greatest resistance rate to metronidazole (91%), but the results in terms of amoxicillin remain contradictory. Nevertheless, the lowest resistance rates in most of the African studies were found for quinolones. Among European children, the most frequent antimicrobial resistance was also noticed for metronidazole and clarithromycin (up to 59% and 45%) but with a predominance for clarithromycin as compared to other continents. The differences in antibiotic use among continents and countries worldwide is clearly responsible for the discrepancies regarding H. pylori antimicrobial-resistance patterns, emphasizing the crucial role of global judicious antibiotic use in order to control the increasing resistance rates worldwide.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] What is the relevance of resistance of Helicobacter pylori to antimicrobial agents?
    Megraud, F
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 1996, 1996, : 348 - 356
  • [32] What is the role of bismuth in Helicobacter pylori antimicrobial resistance?
    Van Zanten, SV
    Chiba, N
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 593 - 599
  • [33] Does bismuth prevent antimicrobial resistance of Helicobacter pylori?
    Williamson, R
    Pipkin, GA
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 1998, 1998, : 416 - 425
  • [34] Molecular Approaches to Identify Helicobacter pylori Antimicrobial Resistance
    Megraud, Francis
    Benejat, Lucie
    Ngoyi, Esther Nina Ontsira
    Lehours, Philippe
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2015, 44 (03) : 577 - +
  • [35] Antimicrobial resistance and virulence in Helicobacter pylori: Genomic insights
    Mehrotra, Tanshi
    Devi, T. Barani
    Kumar, Shakti
    Talukdar, Daizee
    Karmakar, Sonali Porey
    Kothidar, Akansha
    Verma, Jyoti
    Kumari, Shashi
    Alexander, Sneha Mary
    Retnakumar, R. J.
    Devadas, Krishnadas
    Ray, Animesh
    Mutreja, Ankur
    Nair, G. Balakrish
    Chattopadhyay, Santanu
    Das, Bhabatosh
    GENOMICS, 2021, 113 (06) : 3951 - 3966
  • [36] The status of antimicrobial resistance of Helicobacter pylori in eastern Europe
    Boyanova, L
    Mentis, A
    Gubina, M
    Rozynek, E
    Gosciniak, G
    Kalenic, S
    Göral, V
    Kupcinskas, L
    Kantarçeken, B
    Aydin, A
    Archimandritis, A
    Dzierzanowska, D
    Vcev, A
    Ivanova, K
    Marina, M
    Mitov, I
    Petrov, P
    Özden, A
    Popova, M
    CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (07) : 388 - 396
  • [37] Helicobacter pylori antibiotic resistance:: Trends over time
    Lahaie, RG
    Gaudreau, C
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2000, 14 (10): : 895 - 899
  • [38] Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea
    Lee, Jung Won
    Kim, Nayoung
    Choi, Soo In
    Jang, Jae Young
    Song, Chin Hee
    Nam, Ryoung Hee
    Lee, Dong Ho
    HELICOBACTER, 2023, 28 (01)
  • [39] Helicobacter pylori Antimicrobial Resistance Using Next-Generation Sequencing in Stool Samples in a Pediatric Population
    Bonilla, Silvana
    Goldsmith, Jeffrey
    Mitchell, Paul
    Bousvaros, Athos
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (05): : 623 - 627
  • [40] Resistance and previous antimicrobial consumption as important factors for the treatment failure in pediatric patients infected by Helicobacter pylori
    Cibrelus, L.
    Alarcon, T.
    Urruzuno, P.
    Martinez, M.
    Lopez-Brea, M.
    HELICOBACTER, 2007, 12 (04) : 459 - 459